| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6021049 | Journal of Neuroimmunology | 2010 | 5 Pages |
Abstract
Our findings indicate that Natalizumab reduces transmigration not only by blocking VLA-4 but also by down-regulating VCAM-1.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Alban Millonig, Harald Hegen, Franziska Di Pauli, Rainer Ehling, Claudia Gneiss, Martina Hoelzl, Bettina Künz, Andreas Lutterotti, Dagmar Rudzki, Thomas Berger, Markus Reindl, Florian Deisenhammer,